Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
73°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly And Co
Recent news which mentions Eli Lilly And Co
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Business
Health care industry
Diabetes
From
CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
Tags
US: News
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
Tags
Business
Health care industry
Companies
From
CNBC.com News
This key element of ESG investing could drive real change at companies and boost returns
November 18, 2023
Tags
Markets
Target Corp
Investing
From
CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
Tags
Markets
Stock Picks
stocks
From
CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
Tags
Eli Lilly and Co
US: News
Novo Nordisk A/S
From
CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
Mad Money
Stock markets
ServiceNow Inc
From
CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
Tags
Health & Science
Pharmaceuticals
Social issues
From
CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
November 02, 2023
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Breaking news
Companies
Business
From
CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
October 31, 2023
Tags
Health care industry
Breaking News: Earnings
COVID/19
From
CNBC.com News
5 things to know before the stock market opens Monday
October 30, 2023
Tags
Kraft Heinz Co
Business News
Paramount Global
From
CNBC.com News
Cramer's week ahead: Federal Reserve meeting, Apple and Eli Lilly earnings
October 27, 2023
Tags
Amazon/com Inc
Business News
Investment Strategy
From
CNBC.com News
Treasury yields continue retreat after 10-year slips back below 5%
October 24, 2023
Tags
Citigroup Inc
Central Banks
Central banking
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Investment strategy
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Treasury yields rise again as 10-year hovers near 5%
October 23, 2023
Tags
United Airlines Holdings Inc
Delta Air Lines Inc
Bonds
From
CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
Business News
Walmart Inc
Sanofi SA
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Diabetes
Medication
Health care industry
From
CNBC.com News
The S&P 500's top 10 performers since its bear market low — and where Cramer stands on them now
October 13, 2023
Tags
Business
Adobe Inc/
Investment strategy
From
CNBC.com News
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
Tags
stocks
Stock Picks
Markets
From
CNBC.com News
3 moments from October's Monthly Meeting of the CNBC Investing Club with Jim Cramer
October 11, 2023
Tags
Breaking News: Markets
CNBC Investing Club: Analysis
Apple Inc
From
CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
Tags
Eli Lilly and Co
Novo Nordisk A/S
stocks
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Diabetes
Brand acquisitions
Health care industry
From
CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
October 10, 2023
Tags
CNBC Investing Club
Harley/Davidson Inc
Broadcom Inc
From
CNBC.com News
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
October 09, 2023
Tags
CNBC Investing Club: Analysis
Biotech and Pharmaceuticals
Breaking News: Markets
From
CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
October 05, 2023
Tags
Carrier Global Corp
Marathon Petroleum Corp
Investment strategy
From
CNBC.com News
Stocks making the biggest moves midday: Meta, Warby Parker, McCormick and more
October 03, 2023
Tags
Rivian Automotive Inc
Finance
Fiverr International Ltd
From
CNBC.com News
Stocks making the biggest moves premarket: Warby Parker, HP, Point Biopharma and more
October 03, 2023
Tags
Breaking news
Emerson Electric Co
Warner Music Group Corp
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Breaking news
Companies
Health care industry
From
CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.